Immunogenicity and Protective Capacity of Sugar ABC Transporter Substrate-Binding Protein against Streptococcus suis Serotype 2, 7 and 9 Infection in Mice
Author:
Yan Zujie12, Pan Ruyi1, Zhang Junjie1, Sun Jianhe3, Ma Xiaochun1ORCID, Dong Nihua1, Yao Xiaohui1, Wei Jianchao1ORCID, Liu Ke1, Qiu Yafeng1ORCID, Sealey Katie4, Nichols Hester5ORCID, Jarvis Michael A.56, Upton Mathew6ORCID, Li Xiangdong67ORCID, Ma Zhiyong1, Liu Juxiang2ORCID, Li Beibei1ORCID
Affiliation:
1. Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China 2. College of Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China 3. Shanghai Key Laboratory of Veterinary Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China 4. School of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK 5. The Vaccine Group Ltd., Plymouth PL6 8BU, UK 6. School of Biomedical Sciences, University of Plymouth, Plymouth PL4 8AA, UK 7. College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China
Abstract
Background: Streptococcus suis (S. suis) is a Gram-positive bacterium that causes substantial disease in pigs. S. suis is also an emerging zoonoses in humans, primarily in Asia, through the consumption of undercooked pork and the handling of infected pig meat as well as carcasses. The complexity of S. suis epidemiology, characterized by the presence of multiple bacterial serotypes and strains with diverse sequence types, identifies a critical need for a universal vaccine with the ability to confer cross-protective immunity. Highly conserved immunogenic proteins are generally considered good candidate antigens for subunit universal vaccines. Methods: In this study, the cross-protection of the sugar ABC transporter substrate-binding protein (S-ABC), a surface-associated immunogenic protein of S. suis, was examined in mice for evaluation as a universal vaccine candidate. Results: S-ABC was shown to be highly conserved, with 97% amino acid sequence identity across 31 S. suis strains deposited in GenBank. Recombinantly expressed S-ABC (rS-ABC) was recognized via rabbit sera specific to S. suis serotype 2. The immunization of mice with rS-ABC induced antigen-specific antibody responses, as well as IFN-γ and IL-4, in multiple organs, including the lungs. rS-ABC immunization conferred high (87.5% and 100%) protection against challenges with S. suis serotypes 2 and 9, demonstrating high cross-protection against these serotypes. Protection, albeit lower (50%), was also observed in mice challenged with S. suis serotype 7. Conclusions: These data identify S-ABC as a promising antigenic target within a universal subunit vaccine against S. suis.
Funder
National Key Research and Development Program of China Department of Health and Social Care, UK
Reference39 articles.
1. Streptococcus Suis: Past and Present;Staats;Vet. Res. Commun.,1997 2. Vötsch, D., Willenborg, M., Weldearegay, Y.B., and Valentin-Weigand, P. (2018). Streptococcus Suis—The “Two Faces” of a Pathobiont in the Porcine Respiratory Tract. Front. Microbiol., 9. 3. Streptococcus Suis Infections in Humans: The Chinese Experience and the Situation in North America;Gottschalk;Anim. Health Res. Rev.,2007 4. Streptococcus Suis: A New Emerging or an Old Neglected Zoonotic Pathogen?;Gottschalk;Future Microbiol.,2010 5. Segura, M., Aragon, V., Brockmeier, S., Gebhart, C., Greeff, A., Kerdsin, A., O’Dea, M., Okura, M., Saléry, M., and Schultsz, C. (2020). Update on Streptococcus Suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. Suis. Pathogens, 9.
|
|